Evidence map›Paper›PMID 29207614›Full record

ArticleOncotarget2017

Danshen improves survival of patients with advanced lung cancer and targeting the relationship between macrophages and lung cancer cells.

Ching-Yuan Wu, Jong-Yuh Cherng, Yao-Hsu Yang, Chun-Liang Lin, Feng-Che Kuan, Yin-Yin Lin, Yu-Shih Lin, Li-Hsin Shu, Yu-Ching Cheng, Hung Te Liu and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Experimental and therapeutic medicine · 2023
    Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Deletion ofFrontiers in immunology · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Ching-Yuan WuDepartment of Chinese Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.
Jong-Yuh CherngDepartment of Chemistry and Biochemistry, National Chung Cheng University, Taiwan.
Yao-Hsu YangDepartment of Chinese Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.
Chun-Liang LinDepartments of Nephrology, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.
Feng-Che KuanDepartment of Hematology and oncology, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.
Yin-Yin LinDepartment of Chinese Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.
Yu-Shih LinDepartment of Pharmacy, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.
Li-Hsin ShuDepartment of Chinese Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.
Yu-Ching ChengDepartment of Chinese Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.
Hung Te LiuDepartment of Chinese Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.
Ming-Chu LuDepartment of Hematology and oncology, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.
Jthau LungDepartment of Medical Research and Development, Chang Gung Memorial Hospital, Chiayi branch, Taiwan.
Pau-Chung ChenInstitute of Occupational Medicine and Industrial Hygiene, National Taiwan University College of Public Health, Taipei, Taiwan.
Hui Kuan LinDepartment of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kuan-Der LeeDepartment of Hematology and oncology, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.
Ying-Huang TsaiDivision of Pulmonary and Critical Care Medicine of Chang Gung Memorial Hospital, Chiayi, Taiwan, Department of Respiratory Therapy, Chang Gung University, Taoyuan, Taiwan.
Chiayi Chang Gung Memorial Hospital · TWChina Medical University · TWNational Chung Cheng University · TWNational Taiwan University · TWTaipei Medical University Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In traditional Chinese medicine, Salvia miltiorrhiza Bunge (danshen) is widely used in the treatment of numerous cancers. However, its clinical effort and mechanism in the treatment of advanced lung cancer are unclear. In our study, the

Indexed as

CCL2dihydroisotanshinone Ilung cancermacrophageSkp2

Identifiers

PMID29207614
PMCPMC5710895
OpenAlexW2728118235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.